Updated:
Cormorant Global Healthcare Master Fund
Cormorant Global Healthcare Master Fund is a healthcare and life sciences investment fund with offices in Shanghai, London, and San Francisco.
Cormorant Global Healthcare Master Fund
Cormorant Global Healthcare Master Fund was established as a sector-focused investment vehicle, headquartered in Shanghai with additional offices in London and San Francisco. The fund's founding team and ownership structure are not publicly disclosed, though its tri-continental footprint suggests an intent to capture healthcare innovation across Asia, Europe, and North America. The firm's mandate centers on healthcare and life sciences, a vertical that demands deep regulatory, scientific, and market expertise. The fund invests across both public and private markets, targeting companies at various stages of development. Its portfolio likely includes biotech firms in clinical trials, pharmaceutical companies with approved products, medtech innovators, and healthcare service providers. Given the absence of disclosed holdings or co-investors, the full scope of deployment remains opaque. The geographic strategy spans developed markets in the US and Europe, as well as growth opportunities in Asia, particularly China. No public data exists on total assets under management, team size, or professionals. The firm has not disclosed recent operational events, fundraising rounds, or new hires. Adjacent vehicles or philanthropic structures, if any, are unknown. The limited public profile suggests Cormorant operates with a lower external visibility typical of many healthcare-specialist funds. The key structural differentiator is the firm's pure healthcare focus combined with a global office network — a configuration that allows local intelligence gathering in three major innovation hubs. Without disclosed principals or track record, however, the firm's governance, succession, and risk management practices remain unverifiable.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Shanghai
Corporate office
Shanghai, China
Additional offices
London, United Kingdom · San Francisco, United States
Sector focus
Frequently asked questions
What investment stages does Cormorant Global Healthcare Master Fund target?
The fund appears to target both public and private equity opportunities across the healthcare sector. Given the lack of disclosed portfolio companies or stage preferences, the exact stage focus — early-stage venture, growth equity, or public market investments — cannot be confirmed. The tri-continental office network may allow the firm to access deals at multiple stages across different regulatory environments.
Is Cormorant Global Healthcare Master Fund structured as a hedge fund or a private equity fund?
The fund's name includes 'Master Fund,' a structure commonly associated with hedge funds that can hold both long and short positions in public securities. However, the firm's stated focus on healthcare and life sciences, combined with its private equity investment references, suggests it may operate as a hybrid vehicle or a fund of funds. Without public filings or disclosures, the precise legal structure is not verifiable.
Does Cormorant Global Healthcare Master Fund invest outside of healthcare?
Based on the firm's name and available information, Cormorant appears to invest exclusively in healthcare and life sciences. The fund's name explicitly states 'Healthcare Master Fund,' and its office locations in major healthcare innovation hubs — Shanghai, London, and San Francisco — reinforce a sector-specialist mandate. No evidence suggests diversification into other sectors.
Who are the key investment professionals at Cormorant Global Healthcare Master Fund?
The fund has not publicly disclosed its investment team, principals, or portfolio managers. Without a website, LinkedIn presence, or media coverage listing leadership, the identities of the people making investment decisions remain unknown. This lack of transparency is atypical for institutional capital but may reflect a more private operational model.
How does Cormorant Global Healthcare Master Fund source its deal flow?
Deal sourcing methods are not publicly documented. Given the fund's offices in Shanghai, London, and San Francisco, the team likely leverages local networks in each region to identify healthcare investment opportunities. For a healthcare-specialist fund, sourcing often involves relationships with academic medical centers, biotech incubators, and pharmaceutical partners — but no specifics are confirmed.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: